ZMapp Ebola Trial Begins in Liberia, U.S.

The trial is designed to also work with other Ebola treatments, such as Tekmira’s, Yoyama’s and BioCryst’s. Read More

Mallinckrodt Acquires Critical Care Devicemaker Ikaria for $2.3 Billion

Ikaria’s lead product is a device to treat newborns with respiratory illness. Read More
The Solutions Center